It is proposed that a primary mechanism leading to neuronal cell death in common neurodegenerative diseases is interference with proteasome function. This can involve genetic defects, direct inactivation of the proteasome (e.g., by reactive oxygen species), or overloading with proteins. The latter can be caused by excessive production of normal proteins or by the formation of poorly degradable proteins as a result of genetic mutations, faulty posttranslational modification, or protein modification by reactive oxygen or nitrogen species. Blockage of the proteasome leads to increased oxidative and nitrative stress, the latter apparently due to upregulation of nitric oxide synthase. Thus, agents that increase proteasome function may be generally neuroprotective, as may be NOS inhibitors. Proteasome inhibitors should be used with caution as therapeutic agents.
Luis C. Antón, Ulrich Sigmar Schubert, Igor Bačík, Michael F. Princiotta, Pamela A. Wearsch, James S. Gibbs, Patricia M. Day, Claudio Realini, Martin Rechsteiner, Jack R. Bennink, Jonathan W. Yewdell
Angelika Szokalska, Marcin Makowski, Dominika Nowis, Grzegorz M. Wilczyński, Marek Kujawa, Cezary Wójcik, Izabela Młynarczuk-Biały, Paweł Salwa, Jacek Bil, Sylwia Janowska, Patrizia Agostinis, Tom Verfaillie, Marek Bugajski, J Gietka, Tadeusz Issat, Eliza Głodkowska‐Mrówka, Piotr Mrówka, Tomasz Stokłosa, Michael R Hamblin, Paweł Mróz, Marek Jakóbisiak,
Angelika Szokalska, Marcin Makowski, Dominika Nowis, Grzegorz M. Wilczyński, Marek Kujawa, Cezary Wójcik, Izabela Młynarczuk-Biały, Paweł Salwa, Jacek Bil, Sylwia Janowska, Patrizia Agostinis, Tom Verfaillie, Marek Bugajski, J Gietka, Tadeusz Issat, Eliza Głodkowska‐Mrówka, Piotr Mrówka, Tomasz Stokłosa, Michael R Hamblin, Paweł Mróz, Marek Jakóbisiak,
Discussion(0)
No comments yet. Be the first to comment.